Publications
57
Citations
1,625
Est. group size
~5
Recurring co-author estimate
Active years
60
Publishing since 1966
Yohannes A. Mebratu studies how the body's cells respond to influenza and other respiratory virus infections, with a particular focus on programmed cell death pathways (such as the protein Bik and related apoptosis regulators) and how these processes affect viral replication, lung inflammation, and disease severity. The work spans basic molecular virology, mouse models of lung injury and emphysema, and some translational efforts like nasal spray technologies to prevent respiratory infections. This research is relevant to students interested in how host cell biology shapes outcomes in respiratory viral disease and COPD.
Publication output has grown notably over the last decade, rising from a handful of papers per year in 2017-2022 to 6-8 papers annually in 2023-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Polymorphism of BIK as a Host Risk Factor for Severe Influenza
DNA and Cell Biology · 2025
- USP13 protects against influenza virus-induced lung injury by promoting IFN-β production
Physiology · 2025
- Toward a Radically Simple Multi‐Modal Nasal Spray for Preventing Respiratory Infections
Advanced Materials · 2024
- FBXL19 in endothelial cells protects the heart from influenza A infection by enhancing antiviral immunity and reducing cellular senescence programs
American Journal of Physiology-Heart and Circulatory Physiology · 2024
- Influenza A Virus Subverts the Proteasome to Inhibit Degradation of Polyubiquitinated BIK, Promoting Viral Replication in the Airway Epithelial Cells
2024
- Bik promotes proteasomal degradation to control low grade inflammation
UNC Libraries · 2024
- Bik promotes proteasomal degradation to control low-grade inflammation
Journal of Clinical Investigation · 2023
- Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice
Virology Journal · 2023
- Preemptive analgesia role of intravenous diclofenac in abdominal hysterectomy under general anesthesia in a limited resource settings: A prospective cohort study
Research Square · 2023
- Bcl-2 Interacting Killer, Bik, Promotes Influenza A Virus Replication and Severity to Flu
2023
- An Improved Method for Quantifying Emphysema and Establishing a Mouse Model of Emphysema Using Cigarette Smoke Exposure and H1N1 Influenza Virus Infection
2023
- Correction: Independent role of caspases and Bik in augmenting influenza A virus replication in airway epithelial cells and mice
Virology Journal · 2023
- A Drug-Free Pathogen Capture and Neutralizing Nasal Spray to Prevent Emerging Respiratory Infections
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- B‐cell lymphoma‐2 family proteins‐activated proteases as potential therapeutic targets for influenza A virus and severe acute respiratory syndrome coronavirus‐2: Killing two birds with one stone?
Reviews in Medical Virology · 2022
- Inhibition of Caspase Activity Diminishes Influenza A Virus (IAV) Replication in the Airway Epithelial Cells and Protects Mice from IAV-Induced Mortality
2022
- UNC Libraries×3
- American Journal of Respiratory Cell and Molecular Biology×2
- Respiratory Research×2
- Virology Journal×2
- Reviews in Medical Virology×2
- Susan Reed
Medicine · Indiana University
- Chyongchiou J. Lin
Medicine · The Ohio State University
- Fenghua Zhang
Medicine · Purdue University West Lafayette
- Jennifer Schrock
Medicine · The Ohio State University
- Veerupaxagouda Patil
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile